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Abstract
Introduction: Autoimmune cholangitis remains an elusive manifestation of immunoglobulin G4-associated
systemic disease most commonly encountered in patients with autoimmune pancreatitis. No strict diagnostic
criteria have been described to date and diagnosis mainly relies on a combination of clinical and histopathologic
findings. It is hence even more challenging to diagnose autoimmune cholangitis in patients with late or atypical
presentations, such as without concomitant pancreatic involvement. Early diagnosis of this rare disorder can
significantly improve outcomes considering high rates of surgical intervention, as well as high relapse rates in the
absence of steroid treatment. To the best of our knowledge the literature is quite sparse on cases with atypical
presentations of autoimmune cholangitis.
Case presentation: We report a case of a previously healthy 65-year-old man of Middle-Eastern origin, with a
history of pancreatic insufficiency of unknown etiology, evaluated for elevated liver function tests found
incidentally on a routine physical examination. Imaging studies revealed an atrophic pancreas and biliary duct
dilatation consistent with obstruction. Subsequent endoscopic retrograde cholangiopancreatography showed a bile
duct narrowing pattern suggestive of cholangiocarcinoma, but brushings failed to reveal malignant cells. Our
patient proceeded to undergo surgical resection. Histological examination of the resected mass revealed
lymphoplasmacytic infiltrate with no malignant features. Our patient returned three months later with persistently
high liver function tests and no evidence of biliary obstruction on imaging. A presumptive diagnosis of
autoimmune cholangitis was made and our patient’s symptoms resolved after a short course of an oral steroid
regimen. Post factum staining of the resection specimen revealed an immunoglobulin G4 antibody positive
immune cell infiltrate, consistent with the proposed diagnosis.
Conclusion: Our case thus highlights the importance of clinician awareness of the autoimmune spectrum of biliary
pathologies when confronted with atypical clinical presentations, the paucity of diagnostic measures and the
benefit from long-term steroid and/or immunosuppressive treatment.
Introduction
Autoimmune pancreatitis (AIP) was initially described by
Yoshida and colleagues in 1995 to represent a type of
chronic pancreatitis with characteristic histopathologic
and imaging findings [1]. Based on clinical and laboratory
features, two types of AIP are described in the literature.
Type I AIP is thought be a pancreatic manifestation of
immunoglobulin (Ig) G4-associated systemic disease char-
acterized by lymphoplasmacytic infiltrate and serum eleva-
tion of IgG4 levels [2]. Type II AIP shows less correlation
with high IgG4 levels, occurring in a younger population
and typically characterized by granulocytic epithelial
lesions [3].
Although several diagnostic criteria have been pro-
posed for type I AIP such as HISORt [4] and the Asian
Consensus Criteria [5], type II AIP remains largely a clin-
ical diagnosis. Interestingly, it was reported that only 44%
of patients with both types of AIP will have elevated
serum IgG4 levels, rendering the diagnosis in the remain-
der of the group more challenging [6].
The importance of recognizing the possibility of AIP-
associated disease is particularly important in patients
with atypical as well as non-pancreatic presentation, or
those caught in later stages of the disease. Prompt
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initiation of steroid treatment in these individuals could
greatly improve outcomes, at least in part, by the avoid-
ance of surgery. We would thus like to share our experi-
ence in encountering a case of serum IgG4-negative,
steroid-responsive sclerosing cholangitis in a patient with
pancreatic insufficiency.
Case presentation
A previously healthy 65-year-old man of Middle-Eastern
origin, with a past medical history of hypertension, was
initially referred to our gastroenterology service for evalua-
tion of a suspected gastrointestinal bleed. Upper and lower
endoscopies failed to reveal an active source of bleeding at
that time, however he did have Helicobacter pylori-asso-
ciated gastritis, which was treated. On a follow-up
appointment our patient described a history of diarrhea
with passage of greasy stool of several months duration
associated with 13.6 kg weight loss but no associated
abdominal pain. On further questioning, our patient
described a history of binge alcohol consumption over five
years prior to presentation. His physical exam was unre-
markable and laboratory investigations revealed mild ane-
mia, with hemoglobin (Hg) 127 g/L, normal liver function
tests (LFTs), negative stool cultures, increased fecal fat of
72 g/day, fecal elastase below 15 ug/g of stool, and ele-
vated blood sugar. Ultrasound investigation of his abdo-
men was unremarkable and computed tomography (CT)
of his abdomen revealed an atrophic pancreas with no
focal lesions. Our patient was presumed to have chronic
alcoholic pancreatitis, although the absence of abdominal
pain was puzzling, and was prescribed pancreatic enzyme
replacement therapy with significant clinical improvement.
One year later our patient was referred again for an
evaluation of malaise and elevated LFTs; again there was
no complaint of abdominal pain. His alkaline phospha-
tase (ALP) level was found to be 265 U/L, gamma- glu-
tamyltransferase (g-GT) 236 U/L, alanine transaminase
(ALT) 138 U/L and aspartate transaminase (AST) 94 U/
L in the setting of normal lipase and bilirubin levels.
Our patient was not jaundiced on exam; carbohydrate
antigen (CA) 19-9 was elevated at 210 U/ml with a nor-
mal carcinoembryonic antigen (CEA) level. Abdominal
ultrasound revealed right-sided intrahepatic bile duct
dilatation suggestive of an obstruction. A subsequent
abdominal CT scan showed an irregular soft tissue mass
in his right distal hepatic duct proximal to the conflu-
ence (Figure 1A), and a somewhat atrophic pancreas
(Figure 1B). Endoscopic retrograde cholangiopancreato-
graphy (ERCP) shortly after identified a long stenotic
region within the right intrahepatic biliary tree with
mild intermittent left-sided dilatation (Figure 2A). The
overall picture was consistent with a presentation of
Klatskin tumor (a representative picture of which, from
an unrelated patient, is shown in Figure 2B), given the
elevated CA19-9 level. Our patient then underwent bile
duct resection, cholecystectomy and extended right
hepatectomy with Roux-en-Y reconstruction. Intrao-
peratively, a firm mass was palpated at the hilum of his
liver extending into the right ductal system. Our patient
had an uneventful postoperative recovery with complete
normalization of liver enzymes at the time of discharge.
Subsequent results of the pathology revealed a fibroin-
flammatory rather than malignant nature of the resected
mass, with predominance of a lymphoplasmacytic infil-
trate (Figure 3A, B). The liver parenchyma was normal
and bile ducts showed proliferation and fibrosis as well
as moderate chronic inflammatory infiltrate. Post factum
histological staining of the specimen revealed a large
IgG4 antibody positive infiltrate, with 55 positive cells
per high power field (Figure 3C). Additional serological
tests were ordered during a postoperative patient fol-
low-up appointment. These were negative for serum
antinuclear antibody and rheumatoid factor, as well as
showing hypergammaglobulinemia with a surprisingly
low IgG4 level.
The patient returned three months after surgery with
malaise, fatigue and a reduced appetite. His laboratory
studies revealed abnormal liver enzymes: total/direct
bilirubin 21/9 umol/L, ALP 821 U/L, g-GT 624 U/L, ALT
127 U/L and AST 143 U/L. Abdominal ultrasound
revealed the normal appearance of the residual liver with
no biliary tract dilatation. Given the histology and posi-
tive immunochemical staining for IgG4 positive cells, our
patient was then prescribed a trial of a steroid regimen,
which led to complete normalization of liver enzymes
within three months. After tapering of the steroid therapy
three months later our patient developed significant sub-
mandibular gland swelling, which again responded to re-
introduction of corticosteroids. He now remains well on
maintenance azathioprine treatment, 15 months after
presenting with unilateral bile duct obstruction.
Discussion
Autoimmune cholangitis (AIC) is a term that has recently
been coined to describe a sclerosing cholangitis asso-
ciated with IgG4-associated systemic disease. Thus far no
diagnostic criteria have been proposed and it remains lar-
gely a clinical diagnosis based on histopathological and
laboratory parameters. The occasional absence of pan-
creatic involvement in these patients has been previously
reported [7,8].
Despite the rarity of AIC, it remains crucial to be alert
to its possibility, especially in patients with cholangitis
and underlying unexplained pancreatic disease. We have
described a case of a serum IgG4-negative patient who
underwent laparotomy for a suspected Klatskin tumor
that revealed a lymphocytoplasmic infiltrate staining
heavily for IgG4. A previous diagnosis of both endocrine
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Figure 1 Abdominal CT scan. (A) Arrow pointing to bile duct wall thickening. (B) Arrow outlining atrophic pancreas.
A B
Figure 2 ERCP findings. (A) Stenotic region within right intrahepatic biliary tree. (B) Right and left hepatic ductal dilation (short arrows) above
a typical hilar (Klatskin tumor, long arrow) stricture. A guidewire has been passed across the stricture into the right hepatic duct.
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and exocrine pancreatic insufficiency in this patient, with
a remote binge drinking history and no history of abdom-
inal pain, is worth re-examining and possibly attributing
to the late stage of autoimmune pancreatitis. The
remarkable response to steroids further supports an auto-
immune origin.
The natural course of AIP-associated cholangitis
involves relapses. An examination of a series of 53 AIC
patients with a mean follow-up of 38 months demon-
strated relapse of 44% and 53% postoperative and post-
steroid-withdrawal respectively [9]. Similar observations
have been reported in patients with AIP. Kamisawa and
colleagues reviewed 563 patients with AIP and showed a
statistically significant decrease in the relapse rate of
patients treated with maintenance low-dose steroid ther-
apy [10]. It is thus essential to initiate steroid treatment as
soon as the suspicion of an autoimmune component is
strong enough, while awaiting definitive testing.
We have then reviewed the literature in an attempt to
identify what could have aided in the early diagnosis of
this patient and could potentially reduce morbidity asso-
ciated with unnecessary surgical treatment.
The difficulty in preoperative diagnosis was explored by
Itoh et al., where radiographic findings in 15 patients with
a postoperative diagnosis of AIP were reviewed and failed
to demonstrate specific nuances that would differentiate
AIC from other biliary disease [11]. This suggests that
imaging studies, although essential in investigations of
A B
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Figure 3 Histopathology of the resected mass. (A) Hematoxylin and eosin staining showing thickened bile duct. (B) Hematoxylin and eosin
staining revealing lymphoplasmacytic infiltrate, arrow pointing to plasma cell. (C) IgG4 antibody staining revealing more than 55 IgG4 positive
cells per high power field.
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patient symptoms, might not be helpful in detecting the
precise etiology of strictures.
Measurement of serum IgG4 levels is not currently
recommended as routine without a high index of suspi-
cion for autoimmune origin in patients with gastroin-
testinal complaints. In addition, as mentioned
previously, only 44% of patients with IgG4-associated
disease confirmed by biopsy had elevated levels of
serum IgG4, rendering this test of equivocal value.
We then hypothesized that perhaps steroid treatment
should have been initiated right after the histology of the
resected mass described a lymphocytoplasmic infiltrate.
We searched the literature for similar cases, and found
several cases of patients who have undergone laparo-
tomies for suspected malignant bile duct strictures with
postoperative histopathological findings suggestive of
AIC [12,13]. In a recent case series, Erdogan and collea-
gues described 185 patients with benign bile duct stric-
tures who have undergone laparotomy for suspected
malignant disease; 15 of these had lymphocytoplasmic
infiltrate with only two staining positive for IgG4 [14].
This suggests that histopathology alone is insufficient for
the diagnosis and could result in unjustifiably subjecting
patients to steroid regimen side effects. IgG4 antibody
staining, however, seems to be the only test that allows
the diagnosis to be established definitively.
Conclusion
Our case report highlights the importance of clinician
awareness of the possibility of an autoimmune origin of
pancreatitis and cholangitis, especially in patients pre-
senting with atypical or late presentations. The challenge
still lies in the lack of early diagnostic tests to evaluate
biliary strictures that could prevent significant surgical
interventions in these patients. Routine IgG4 staining on
benign lesions obtained at biopsy in patients with
obstructive cholangitis could potentially aid in early
initiation of steroid treatment.
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